Clinical Trial Update: Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating zoledronic acid with calcium and vitamin D to prevent bone loss in women undergoing adjuvant chemotherapy for breast cancer; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Osteoporosis

Drugs mentioned

• Calcium (Calcium)
• Vitamin D (Cholecalciferol)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Breast Cancer, Osteoporosis | Phase 3 | Status: COMPLETED